A machine learning approach for differentiating malignant from benign enhancing foci on breast MRI.

Journal: European radiology experimental
PMID:

Abstract

BACKGROUND: Differentiate malignant from benign enhancing foci on breast magnetic resonance imaging (MRI) through radiomic signature.

Authors

  • Natascha C D'Amico
    Unit of Diagnostic Imaging and Stereotactic Radiotherapy, Centro Diagnostico Italiano S.p.A., Via Saint Bon 20, 20147, Milan, Italy. nataschaclaudia.damico@cdi.it.
  • Enzo Grossi
    Villa Santa Maria Foundation, Tavernerio, Italy. enzo.grossi@bracco.com.
  • Giovanni Valbusa
    Bracco Imaging SpA, Milano, Italy. giovanni.valbusa@bracco.com.
  • Francesca Rigiroli
    Università degli Studi di Milano, Scuola di specializzazione di Radiodiagnostica, Via Festa del Perdono 7, Milan, Italy.
  • Bernardo Colombo
    Unit of Diagnostic Imaging and Stereotactic Radiotherapy, Centro Diagnostico Italiano S.p.A., Via Saint Bon 20, 20147, Milan, Italy.
  • Massimo Buscema
    Semeion Research Center,00128 Rome,Italy.m.buscema@semeion.it.www.semeion.itwww.researchgate.net/profile/Massimo_Buscema.
  • Deborah Fazzini
    Unit of Diagnostic Imaging and Stereotactic Radiotherapy, Centro Diagnostico Italiano S.p.A., Via Saint Bon 20, 20147, Milan, Italy.
  • Marco Ali
    Unit of Diagnostic Imaging and Stereotactic Radiotherapy, Centro Diagnostico Italiano S.p.A., Via Saint Bon 20, 20147, Milan, Italy.
  • Ala Malasevschi
    Unit of Diagnostic Imaging and Stereotactic Radiotherapy, Centro Diagnostico Italiano S.p.A., Via Saint Bon 20, 20147, Milan, Italy.
  • Gianpaolo Cornalba
    Unit of Diagnostic Imaging and Stereotactic Radiotherapy, Centro Diagnostico Italiano S.p.A., Via Saint Bon 20, 20147, Milan, Italy.
  • Sergio Papa
    Unit of Diagnostic Imaging and Stereotactic Radiotherapy, Centro Diagnostico Italiano S.p.A., Via Saint Bon 20, 20147, Milan, Italy.